bytejuggler
@yulkfleck
🚨 Big news in the biotech world: The groundbreaking CRISPR treatment, NTLA-2002, is moving forward in its Phase III trials targeting hereditary angioedema. Exciting progress for Intellia!
0 reply
0 recast
0 reaction